Linda Gil v. HHS - Influenza, Guillain-Barré syndrome (GBS) (2026)

Linda Gil filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that she suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on September 19, 2022. She stated that the vaccine was administered in the United States, that she suffered residual effects for more than six months, and that there had been no prior award or settlement.

The respondent, the Secretary of Health and Human Services, filed a Rule 4(c) report conceding that Ms. Gil is entitled to compensation.

The respondent stated that medical personnel reviewed the petition and medical records and concluded that Ms. Gil satisfied the criteria set forth in the Vaccine Injury Table for GBS, with onset between three and forty-two days after vaccination and no apparent alternative cause.

The respondent also confirmed that the statutory six-month sequelae requirement was satisfied. Based on the respondent's concession and the evidence of record, the Chief Special Master found that Petitioner is entitled to compensation.